Chemoinformaics analysis of 2,3,4-Trimethylpentanoic acid
Molecular Weight | 144.214 | nRot | 3 |
Heavy Atom Molecular Weight | 128.086 | nRig | 13 |
Exact Molecular Weight | 144.115 | nRing | 0 |
Solubility: LogS | -5.004 | nHRing | 0 |
Solubility: LogP | 4.284 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 25.6327 |
nHD | 1 | BPOL | 16.9193 |
QED | 0.664 |
Synth | 4.395 |
Natural Product Likeliness | 3.017 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.652 |
MDCK | 0.0000161 |
BBB | 0.926 |
PPB | 0.934066 |
VDSS | 1.178 |
FU | 0.0866638 |
CYP1A2-inh | 0.127 |
CYP1A2-sub | 0.638 |
CYP2c19-inh | 0.229 |
CYP2c19-sub | 0.939 |
CYP2c9-inh | 0.315 |
CYP2c9-sub | 0.665 |
CYP2d6-inh | 0.014 |
CYP2d6-sub | 0.663 |
CYP3a4-inh | 0.103 |
CYP3a4-sub | 0.324 |
CL | 11.11 |
T12 | 0.075 |
hERG | 0.029 |
Ames | 0.022 |
ROA | 0.078 |
SkinSen | 0.27 |
Carcinogencity | 0.035 |
EI | 0.093 |
Respiratory | 0.937 |
NR-Aromatase | 0.067 |
Antiviral | No |
Prediction | 0.940148 |